MXCT · Healthcare · $126M
$1.18+1.72%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“2분기 매출은 730만 달러로 직전 분기 1,000만 달러에서 다시 줄었지만, 회사는 상반기 매출을 안정화했다는 판단을 유지하고 있어요.”
In the company's words · 2026 2분기 earnings call